Cargando…
The Challenges of Canadian Pharmacare Are More Complicated Than Acknowledged Comment on "Universal Pharmacare in Canada"
This commentary considers two editorial pieces, written by Hajizadeh and Edmonds, and Lewis, which address universal pharmacare in Canada. The pieces focus on the social inequities of the existing system and the challenges of successful implementation. After identifying the significant strengths of...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Kerman University of Medical Sciences
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7947897/ https://www.ncbi.nlm.nih.gov/pubmed/32610780 http://dx.doi.org/10.15171/ijhpm.2020.20 |
_version_ | 1783663323183579136 |
---|---|
author | Acri née Lybecker, Kristina M. L. |
author_facet | Acri née Lybecker, Kristina M. L. |
author_sort | Acri née Lybecker, Kristina M. L. |
collection | PubMed |
description | This commentary considers two editorial pieces, written by Hajizadeh and Edmonds, and Lewis, which address universal pharmacare in Canada. The pieces focus on the social inequities of the existing system and the challenges of successful implementation. After identifying the significant strengths of both articles, this commentary then delves into the reasons why universal pharmacare may not be the solution, and identifies numerous thorny issues that will complicate the implementation of such a publicly funded program. Both discussions point to the need for caution and transparency going forward. |
format | Online Article Text |
id | pubmed-7947897 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Kerman University of Medical Sciences |
record_format | MEDLINE/PubMed |
spelling | pubmed-79478972021-03-16 The Challenges of Canadian Pharmacare Are More Complicated Than Acknowledged Comment on "Universal Pharmacare in Canada" Acri née Lybecker, Kristina M. L. Int J Health Policy Manag Commentary This commentary considers two editorial pieces, written by Hajizadeh and Edmonds, and Lewis, which address universal pharmacare in Canada. The pieces focus on the social inequities of the existing system and the challenges of successful implementation. After identifying the significant strengths of both articles, this commentary then delves into the reasons why universal pharmacare may not be the solution, and identifies numerous thorny issues that will complicate the implementation of such a publicly funded program. Both discussions point to the need for caution and transparency going forward. Kerman University of Medical Sciences 2020-02-15 /pmc/articles/PMC7947897/ /pubmed/32610780 http://dx.doi.org/10.15171/ijhpm.2020.20 Text en © 2021 The Author(s); Published by Kerman University of Medical Sciences This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Commentary Acri née Lybecker, Kristina M. L. The Challenges of Canadian Pharmacare Are More Complicated Than Acknowledged Comment on "Universal Pharmacare in Canada" |
title | The Challenges of Canadian Pharmacare Are More Complicated Than Acknowledged Comment on "Universal Pharmacare in Canada" |
title_full | The Challenges of Canadian Pharmacare Are More Complicated Than Acknowledged Comment on "Universal Pharmacare in Canada" |
title_fullStr | The Challenges of Canadian Pharmacare Are More Complicated Than Acknowledged Comment on "Universal Pharmacare in Canada" |
title_full_unstemmed | The Challenges of Canadian Pharmacare Are More Complicated Than Acknowledged Comment on "Universal Pharmacare in Canada" |
title_short | The Challenges of Canadian Pharmacare Are More Complicated Than Acknowledged Comment on "Universal Pharmacare in Canada" |
title_sort | challenges of canadian pharmacare are more complicated than acknowledged comment on "universal pharmacare in canada" |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7947897/ https://www.ncbi.nlm.nih.gov/pubmed/32610780 http://dx.doi.org/10.15171/ijhpm.2020.20 |
work_keys_str_mv | AT acrineelybeckerkristinaml thechallengesofcanadianpharmacarearemorecomplicatedthanacknowledgedcommentonuniversalpharmacareincanada AT acrineelybeckerkristinaml challengesofcanadianpharmacarearemorecomplicatedthanacknowledgedcommentonuniversalpharmacareincanada |